Results
3043
Most Popular Stocks on the market
3043 companies
Xintela
Market Cap: SEK 270.7m
A biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy.
XINT
SEK 0.39
7D
-11.8%
1Y
-17.7%
Cadrenal Therapeutics
Market Cap: US$28.7m
Operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions.
CVKD
US$14.03
7D
6.5%
1Y
-3.2%
FLUENT
Market Cap: US$28.7m
Through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.
FNT.U
US$0.045
7D
-10.0%
1Y
-74.3%
Prescient Therapeutics
Market Cap: AU$43.6m
A clinical stage oncology company, develops drugs for the treatment of various cancers in Australia.
PTX
AU$0.042
7D
-1.2%
1Y
6.4%
Human Metabolome Technologies
Market Cap: JP¥4.3b
Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.
6090
JP¥750.00
7D
3.7%
1Y
21.6%
FunPep
Market Cap: JP¥4.3b
Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides.
4881
JP¥105.00
7D
-3.7%
1Y
-27.1%
Rubicon Organics
Market Cap: CA$39.6m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.59
7D
0%
1Y
34.1%
BDH Industries
Market Cap: ₹2.5b
Engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India and Internationally.
524828
₹435.80
7D
0.6%
1Y
31.2%
JSP Pharmaceutical Manufacturing (Thailand) Public
Market Cap: ฿911.2m
JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.
JSP
฿1.92
7D
6.1%
1Y
-9.4%
Carna Biosciences
Market Cap: JP¥4.2b
A clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan.
4572
JP¥221.00
7D
-0.9%
1Y
-43.6%
Regent Pacific Group
Market Cap: HK$218.9m
An investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific.
575
HK$0.75
7D
-5.1%
1Y
87.5%
Aptamer Group
Market Cap: UK£20.9m
Provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.
APTA
UK£0.0077
7D
-20.5%
1Y
229.8%
Klotho Neurosciences
Market Cap: US$27.9m
Develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders.
KLTO
US$0.45
7D
-17.6%
1Y
-38.1%
Syschem (India)
Market Cap: ₹2.5b
Engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India.
531173
₹56.72
7D
2.8%
1Y
33.4%
BioLASCO Taiwan
Market Cap: NT$847.8m
Provides bio-materials and surgical services in Taiwan and internationally.
6662
NT$33.10
7D
-1.2%
1Y
-9.3%
Fusion Antibodies
Market Cap: UK£20.7m
A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.
FAB
UK£0.18
7D
9.0%
1Y
319.5%
Vitura Health
Market Cap: AU$42.4m
Engages in the sale and distribution of medicinal cannabis products in Australia.
VIT
AU$0.064
7D
0%
1Y
-12.3%
Beit Jala Pharmaceutical
Market Cap: د.أ19.6m
Engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority.
BJP
د.أ2.80
7D
0%
1Y
n/a
LAUNXP Biomedical
Market Cap: NT$842.2m
Engages in the research and development of drugs for cancer patients.
6876
NT$25.95
7D
0.8%
1Y
30.1%
DT&CRO
Market Cap: ₩38.9b
Operates as a full-service CRO provider in South Korea.
A383930
₩3,040.00
7D
-5.0%
1Y
-60.6%
Daré Bioscience
Market Cap: US$27.5m
Develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States.
DARE
US$2.09
7D
-1.4%
1Y
-36.1%
Rein Therapeutics
Market Cap: US$27.5m
A biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States.
RNTX
US$1.18
7D
-2.5%
1Y
-67.7%
Gemina Laboratories
Market Cap: CA$38.3m
A biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada.
GLAB
CA$0.50
7D
0%
1Y
11.1%
ProText Mobility
Market Cap: US$27.3m
A biotech company, engages in the development of pharmaceutical botanical medicines.
TXTM
US$0.0031
7D
3.3%
1Y
55.0%
European Medical Solutions
Market Cap: €23.3m
Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium.
ALEMS
€5.50
7D
-4.2%
1Y
-18.6%
Vidac Pharma Holding
Market Cap: €23.2m
An investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases.
T9G
€0.45
7D
-8.2%
1Y
28.6%
Seach Medical Group
Market Cap: ₪90.9m
Manufactures and sells medicinal cannabis products worldwide.
SEMG
₪2.75
7D
0.1%
1Y
37.3%
BCWORLD PHARM
Market Cap: ₩38.1b
Operates as a pharmaceutical company in South Korea.
A200780
₩4,510.00
7D
3.2%
1Y
-1.4%
IRLAB Therapeutics
Market Cap: SEK 253.1m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.
IRLAB A
SEK 2.98
7D
-2.9%
1Y
-75.4%
Epibiotech
Market Cap: ₩37.8b
A biopharmaceutical research company, develops cell and antibody treatments for hair restoration medical needs.
A446440
₩16,390.00
7D
0.6%
1Y
56.1%
Sat Kartar Shopping
Market Cap: ₹2.4b
An ayurvedic healthcare company, provides ayurvedic products in India.
SATKARTAR
₹151.10
7D
-5.5%
1Y
n/a
Syntara
Market Cap: AU$40.8m
Operates as a clinical-stage drug development company that targets extracellular matrix dysfunction through amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis in Australia.
SNT
AU$0.025
7D
-3.8%
1Y
-35.9%
Kezar Life Sciences
Market Cap: US$26.7m
A clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States.
KZR
US$3.65
7D
-2.9%
1Y
-32.9%
GenSight Biologics
Market Cap: €22.8m
A clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.
SIGHT
€0.15
7D
-0.1%
1Y
-56.6%
Cryosite
Market Cap: AU$40.8m
Provides outsourced clinical trials logistic services in Australia.
CTE
AU$0.83
7D
-0.6%
1Y
4.4%
Baskhanbio Pharma
Market Cap: ₩37.5b
Provides pain medicines before and after surgery, and medical devices for surgical process in South Korea.
A354390
₩5,340.00
7D
-0.4%
1Y
21.4%